IGC Pharma's total assets for Q1 2027 were $9.50M, an increase of 3.39% from the previous quarter. IGC total liabilities were $3.36M for the fiscal quarter, a 9.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.